A previous study with patients suffering from 11 different autoimmune diseases, excluding SSc, confirmed that LD-IL2 significantly increased the number of regulatory T cells and was safe, without activating effector T cells [66]. The gene discussed is IL2; the disease is systemic sclerosis.